Pavlov Institute of Physiology, Russian Academy of Sciences — Aires Research Partner
Pavlov Institute of Physiology, Russian Academy of Sciences
Location: St. Petersburg, Russia
Type: Federal research institution, Russian Academy of Sciences (RAS)
Role in Aires Program: Primary biological research partner — 20+ studies across 3 decades
Independence: Partner institution; research conducted in academic collaboration
About the Institution
The Pavlov Institute of Physiology is one of Russia's oldest and most distinguished biomedical research centers, founded under the Russian Academy of Sciences in St. Petersburg. Named after Nobel Prize-winning physiologist Ivan Pavlov, the Institute operates a research program spanning neurophysiology, cardiovascular physiology, genetics, and cellular biology.
The Pavlov Institute has served as the primary biological research institution for the Aires program since the early 2000s, spanning electroencephalography (EEG), heart rate variability (HRV), cytogenetics, animal behavioral studies, and clinical endpoint measurements across all three generations of Aires resonator products.
EEG and Brain Activity Research
The Pavlov Institute's neuroscience team has produced the largest body of EEG research in the Aires corpus — spanning two decades and three product generations. Principal researchers include Dr. Larisa Rybina and Dr. Vladimir Sysoev.
- 2003 — Rybina NV, Alexandrov AA: EEG normalization under mobile phone EMF; Aires NEMA (Gen 1). First formal Aires biological study.
- 2003 — Rybina NV: Comparative EEG — Aires NEMA vs. 5 competitor devices. Aires outperformed all 5 on EEG normalization.
- 2006 — Serov, Sysoev, Rybina et al.: Joint physics-biology paper in Nanotech journal — first peer-reviewed paper bridging resonator physics and biological EEG effects.
- 2014 — Sysoev SV, Serov IA: EEG normalization under GSM-900 cellular EMF; Aires Shield (Gen 2).
- 2019 — Pavlov team: Cerebral Bioelectrical Activity study; Aires Shield Pro (Gen 2).
- 2020 — Rybina NV: Two reports on Lifetune Gen 3 EEG — first tests of the current product line; cohort aged 40–60.
- 2025 — Sysoev SV, Rybina NV: Five-stage EEG protocol; Lifetune ONE — most methodologically detailed EEG design in the corpus.
Cytogenetics and DNA Integrity Research
A five-stage cytogenetics program (2016–2019) led by Dr. Natalya Dyuzhikova examined chromosomal aberrations in rat bone marrow under WiFi exposure.
- Stage I (2016): WiFi increased chromosomal aberrations from 1.9% (control) to 9.8% — a 5-fold increase. Aires Defender reduced to 2.7%. p≤0.001.
- Stages II–V (2017–2019): Replicated across two rat genotype lines; extended to memory, behavior, and locomotion endpoints. Consistent protective direction.
- Published 2019: Core findings in Ecological Genetics. DOI: 10.17816/ecogen17283-92.
Honeybee Memory Studies
Led by Dr. Natalia Lopatina, the bee program examined WiFi effects on honeybee memory across two years.
- 2019 — 2-year WiFi study: Significant suppression of bee short-term memory (STM) and food motivation. Published in Entomological Review. DOI: 10.1134/S0367144519010039.
- 2020 — STM vs. LTM: Aires protected long-term memory (LTM restored to control) but STM remained suppressed — reflecting different memory consolidation mechanisms. Published in Integrative Physiology. DOI: 10.33910/2687-1270-2020-1-3-231-241.
Most Recent Research (2025)
The SFERA program (2025) tested Lifetune Zone Max (Gen 3) against WiFi 6. Blood parameters and behavior in rats maintained the protective direction — the first validation with the current WiFi 6 standard and current-generation product.
Key Researchers
- Dr. Larisa Rybina — Neurophysiology; lead EEG researcher 2003–2025
- Dr. Vladimir Sysoev — Neurophysiology; EEG co-lead; 2014 and 2025 protocols
- Dr. Natalya Dyuzhikova — Genetics; led the five-stage cytogenetics program and SFERA 2025